-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FpQQYHbjEmb/mCgQCGHBcsj/ibTx03TOiSijEUNgQ9Eb+gz6S98SF8qRmRkVcZUV ChyQAOmo6WvQ62csINZUhw== 0001108017-07-000675.txt : 20071001 0001108017-07-000675.hdr.sgml : 20071001 20071001171939 ACCESSION NUMBER: 0001108017-07-000675 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071001 DATE AS OF CHANGE: 20071001 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Opexa Therapeutics, Inc. CENTRAL INDEX KEY: 0001069308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760333165 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-81104 FILM NUMBER: 071146856 BUSINESS ADDRESS: STREET 1: 2635 N. CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: (281) 272-9331 MAIL ADDRESS: STREET 1: 2635 N. CRESCENT RIDGE DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 FORMER COMPANY: FORMER CONFORMED NAME: PharmaFrontiers Corp. DATE OF NAME CHANGE: 20051011 FORMER COMPANY: FORMER CONFORMED NAME: PHARMAFRONTIERS CORP DATE OF NAME CHANGE: 20040816 FORMER COMPANY: FORMER CONFORMED NAME: SPORTAN UNITED INDUSTRIES INC DATE OF NAME CHANGE: 19990305 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Victory Park Master Fund, Ltd. CENTRAL INDEX KEY: 0001413835 IRS NUMBER: 260686389 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O WALKERS SPV LIMITED, WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1 9002 BUSINESS PHONE: 345-949-0100 MAIL ADDRESS: STREET 1: C/O WALKERS SPV LIMITED, WALKER HOUSE STREET 2: 87 MARY STREET CITY: GEORGE TOWN STATE: E9 ZIP: KY1 9002 SC 13G 1 opexa13g.htm opexa13g.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
 
(Amendment No. __)*
 
Opexa Therapeutics, Inc.
(Name of Issuer)
 
Common Stock, $.50 par value
(Title of Class of Securities)
 
68372T103
(CUSIP Number)
 
September 19, 2007
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
      [    ]                      Rule 13d-1(b)
      [ x ]                      Rule 13d-1(c)
      [    ]                      Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 

-1-

13G
CUSIP No. 68372T103

 
1. 
 
Names of Reporting Persons
Victory Park Capital Advisors, LLC
 
I.R.S. Identification Nos. of Above Persons (entities only)
 
 
2. 
 
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)             ¨
(b)             ¨
 
3. 
 
SEC Use Only
 
 
4. 
 
Citizenship or Place of Organization
Delaware
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
5. 
 
Sole Voting Power
0
 
6. 
 
Shared Voting Power
668,315
 
7. 
 
Sole Dispositive Power
0
 
8. 
 
Shared Dispositive Power
668,315
 
9. 
 
Aggregate Amount Beneficially Owned by Each Reporting Person
668,315*
 
10. 
 
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)¨
 
 
11. 
 
Percent of Class Represented by Amount in Row (9)
9.9%
 
12. 
 
Type of Reporting Person (See Instructions)
OO
 
*   Excludes 320,000 shares issuable upon exercise of warrants which are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of the common stock of Opexa Therapeutics, Inc.
-2-

13G
CUSIP No. 68372T103
 
 
1. 
 
Names of Reporting Persons
Victory Park Master Fund, Ltd.
 
I.R.S. Identification Nos. of Above Persons (entities only)
 
 
2. 
 
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)             ¨
(b)             ¨
 
3. 
 
SEC Use Only
 
 
4. 
 
Citizenship or Place of Organization
Cayman Islands
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
5. 
 
Sole Voting Power
0
 
6. 
 
Shared Voting Power
668,315
 
7. 
 
Sole Dispositive Power
0
 
8. 
 
Shared Dispositive Power
668,315
 
9. 
 
Aggregate Amount Beneficially Owned by Each Reporting Person
668,315*
 
10. 
 
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)¨
 
 
11. 
 
Percent of Class Represented by Amount in Row (9)
9.9%
 
12. 
 
Type of Reporting Person (See Instructions)
OO
 
*  Excludes 320,000 shares issuable upon exercise of warrants which are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of the common stock of Opexa Therapeutics, Inc.
-3-

13G
CUSIP No. 68372T103

 
1. 
 
Names of Reporting Persons
Jacob Capital, L.L.C.
 
I.R.S. Identification Nos. of Above Persons (entities only)
 
 
2. 
 
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)             ¨
(b)             ¨
 
3. 
 
SEC Use Only
 
 
4. 
 
Citizenship or Place of Organization
Illinois
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
5. 
 
Sole Voting Power
0
 
6. 
 
Shared Voting Power
668,315
 
7. 
 
Sole Dispositive Power
0
 
8. 
 
Shared Dispositive Power
668,315
 
9. 
 
Aggregate Amount Beneficially Owned by Each Reporting Person
668,315*
 
10. 
 
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)¨
 
 
11. 
 
Percent of Class Represented by Amount in Row (9)
9.9%
 
12. 
 
Type of Reporting Person (See Instructions)
OO
 
*   Excludes 320,000 shares issuable upon exercise of warrants which are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of the common stock of Opexa Therapeutics, Inc.
 
-4-

13G
CUSIP No. 68372T103
 
 
1. 
 
Names of Reporting Persons
Richard Levy
 
I.R.S. Identification Nos. of Above Persons (entities only)
 
 
2. 
 
Check the Appropriate Box if a Member of a Group (See Instructions)
(a)             ¨
(b)             ¨
 
3. 
 
SEC Use Only
 
 
4. 
 
Citizenship or Place of Organization
USA
 
Number of Shares Beneficially Owned by Each Reporting Person With
 
5. 
 
Sole Voting Power
0
 
6. 
 
Shared Voting Power
668,315
 
7. 
 
Sole Dispositive Power
0
 
8. 
 
Shared Dispositive Power
668,315
 
9. 
 
Aggregate Amount Beneficially Owned by Each Reporting Person
668,315*
 
10. 
 
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)¨
 
 
11. 
 
Percent of Class Represented by Amount in Row (9)
9.9%
 
12. 
 
Type of Reporting Person (See Instructions)
IN
 
*   Excludes 320,000 shares issuable upon exercise of warrants which are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants to the extent that such exercise would result in the holder being deemed the beneficial owner of more than 9.99% of the issued and outstanding shares of the common stock of Opexa Therapeutics, Inc.
 
-5-

 
Item 1(a)
 
Name of Issuer:
   
 
Opexa Therapeutics, Inc. (the “Issuer”)
   
Item 1(b)
Address of Issuer’s Principal Executive Offices:
   
 
2635 North Crescent Ridge Drive
 
The Woodlands, TX 77381
   
Item 2(a)
Name of Person Filing:
   
 
Victory Park Capital Advisors, LLC
 
Victory Park Master Fund, Ltd.
 
Jacob Capital, L.L.C.
 
Richard Levy
   
 
Victory Park Capital Advisors, LLC is the investment manager for Victory Park Master Fund, Ltd.  Jacob Capital, L.L.C. is the manager of Victory Park Capital Advisors, LLC.  Richard Levy is the sole member of Jacob Capital, L.L.C and sole manager of Victory Park Capital Advisors, LLC.
   
Item 2(b)
Address of Principal Business Office or, if none, Residence:
   
 
The business address for each of the reporting persons, other than Victory Park Master Fund, Ltd., is 227 West Monroe Street, Suite 3900, Chicago, Illinois 60606.  The business address for Victory Park Master Fund, Ltd. is c/o Walkers SPV Limited, Walker House, 87 Mary Street, George Town, Grand Cayman, KY1 9002 Cayman Islands.
   
Item 2(c)
Citizenship:
   
 
Victory Park Capital Advisors, LLC is a Delaware limited liability company.
 
Victory Park Master Fund, Ltd. is a Cayman Islands exempted company.
 
Jacob Capital, L.L.C. is an Illinois limited liability company.
 
Richard Levy is a citizen of the United States.
   
Item 2(d)
Title of Class of Securities:
   
 
Common Stock, par value per share $.50 (the “Common Stock”)
   
Item 2(e)
CUSIP Number:
   
 
68372T103
   
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
   
 
Not Applicable
   
Item 4.
Ownership
   
 
As of September 19, 2007:
   
 
(a)           Amount beneficially owned:
   
 
 
Victory Park Capital Advisors, LLC
668,315 shares
 
Victory Park Master Fund, Ltd.
668,315 shares
 
Jacob Capital, L.L.C.
668,315 shares
 
Richard Levy
668,315 shares
 
 
 
Each of the reporting persons may be deemed to be the beneficial owner of warrants to acquire 320,000 shares of the Issuer’s common stock. Victory Park Master Fund, Ltd. is the record holder of the warrants.  The warrants contain a contractual provision blocking exercise of the warrants when the holder beneficially owns more than 9.99% of the issued and outstanding shares of the Issuer.  Since the reporting persons currently beneficially own the maximum amount permitted under the blocker, the warrants are not exercisable and consequently, the shares underlying the warrants have not been included in the number of shares beneficially owned by the reporting persons
   
(b)           Percent of class:
 
 
Victory Park Capital Advisors, LLC
9.9%
 
Victory Park Master Fund, Ltd.
9.9%
 
Jacob Capital, L.L.C.
9.9%
 
Richard Levy
9.9%
   
(c)           Number of shares as to which the person has:
   
 
(i)           Sole power to vote or to direct the vote
 
 
Victory Park Capital Advisors, LLC
0 shares
 
Victory Park Master Fund, Ltd.
0 shares
 
Jacob Capital, L.L.C.
0 shares
 
Richard Levy
0 shares
 
(ii)           Shared power to vote or to direct the vote
 
 
Victory Park Capital Advisors, LLC
668,315 shares
 
Victory Park Master Fund, Ltd.
668,315 shares
 
Jacob Capital, L.L.C.
668,315 shares
 
Richard Levy
668,315 shares
 
(iii)           Sole power to dispose or direct the disposition of
 
 
Victory Park Capital Advisors, LLC
0 shares
 
Victory Park Master Fund, Ltd.
0 shares
 
Jacob Capital, L.L.C.
0 shares
 
Richard Levy
0 shares
 
(iv)           Shared power to dispose or to direct the disposition of
   
 
Victory Park Capital Advisors, LLC
668,315 shares
 
Victory Park Master Fund, Ltd.
668,315 shares
 
Jacob Capital, L.L.C.
668,315 shares
 
Richard Levy
668,315 shares
-6-

Item 5.
Ownership of Five Percent or Less of a Class
   
 
Not applicable  
   
Item 6.
Ownership of More than Five Percent on Behalf of Another Person
   
 
Not Applicable.
   
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
   
 
Not Applicable.
   
Item 8.
Identification and Classification of Members of the Group
   
 
Not Applicable.
   
Item 9.
Notice of Dissolution of Group
   
 
Not Applicable.
   
Item 10.
Certification
   
 
By signing below each of Victory Park Capital Advisors, LLC, Victory Park Master Fund, Ltd., Jacob Capital, L.L.C. and Richard Levy certify that, to the best of such reporting person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
-7-

 
SIGNATURE
 
After reasonable inquiry and to the best of their knowledge and belief, each of Victory Park Capital Advisors, LLC, Victory Park Master Fund, Ltd., Jacob Capital, L.L.C. and Richard Levy certify that the information set forth in this statement is true, complete and correct.
 
Date:  October 1, 2007
 

 
VICTORY PARK CAPITAL ADVISORS, LLC

By:           Jacob Capital, L.L.C., its Manager

By: /s/ Richard Levy
      Name: Richard Levy
      Title: Sole Member
 
 
VICTORY PARK MASTER FUND, LTD.


By: /s/ Richard Levy
      Name: Richard Levy
      Title: Attorney-in-Fact
 
 
JACOB CAPITAL, L.L.C.


By: /s/ Richard Levy
      Name: Richard Levy
      Title: Sole Member


 
By: /s/ Richard Levy
Richard Levy



-8-

EXHIBIT 1
 
 
JOINT FILING AGREEMENT
 
 
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of Opexa Therapeutics, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 1st day of October, 2007.
 
 
    VICTORY PARK CAPITAL ADVISORS, L.L.C.
 
    By: Jacob Capital , L.L.C., its Manager
 
    By: /s/ Richard Levy
    Name: Richard Levy
    Title: Sole Member
 
    VICTORY PARK MASTER FUND, LTD.
 
    By: /s/ Richard Levy
    Name: Richard Levy
    Title: Attorney-in-Fact
 
    JACOB CAPITAL, L.L.C.
 
    By: /s/ Richard Levy
    Name: Richard Levy
    Title: Sole Member
 
 
    By: /s/ Richard Levy
    Richard Levy
 

EXHIBIT 2
 
POWER OF ATTORNEY
FOR CERTAIN FILINGS
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
Ronan Guilfoyle and Roger H. Hanson, each hereby make, constitute and appoint each of:
 
 
Richard Levy, and
Matthew Ray,
 
 
acting individually, as each of our agents and attorneys-in-fact, with full power of substitution, for the purpose of, from time to time, executing in either of our names and/or our capacities as directors of Victory Park Master Fund, Ltd. all documents, certificates, instruments, statements, other filings, and amendments to the forgoing (collectively, “documents”) determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including without limitation Forms 3, 4, 5, 13D, 13F, and 13G required to be filed with the Securities and Exchange Commission; and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority. Any such determination shall be conclusively evidenced by such person’s execution, delivery, furnishing, and/or filing of the applicable document.
 
 
IN WITNESS HEREOF, I have executed this instrument as of the date set forth below.
 
 
Date: September 28, 2007
 
 
/s/ Ronan Guilfoyle
Ronan Guilfoyle,
as Director of Victory Park Master Fund, Ltd.
 
 
/s/ Roger H. Hanson
Roger H. Hanson,
as Director of Victory Park Master Fund, Ltd.
 
 


 

-----END PRIVACY-ENHANCED MESSAGE-----